Clinical Research Directory
Browse clinical research sites, groups, and studies.
Ultraformer MPT Combined With Fractional CO2 Versus Fractional CO2 Alone for Facial Rejuvenation
Sponsor: Clinique Face MD
Summary
This pilot study compares fractional CO2 laser resurfacing alone with the same laser combined, in the same session, with micro-focused ultrasound (Ultraformer MPT) for signs of facial skin aging in women aged 50 to 65. Both devices are licensed by Health Canada and are used within their licensed indications. Each participant's two facial sides are compared: one side, chosen at random, receives the combination and the other side receives the laser alone. The second side receives the ultrasound at Month 3, so both sides end with the combination. Ten participants are enrolled at one clinic in Montreal and followed for 6 months. As a pilot, the study estimates the size and variability of the difference between sides to inform a larger trial.
Official title: A Prospective, Randomized, Hemiface-Controlled Pilot Study Evaluating Ultraformer MPT Combined With Fractional CO2 Versus Fractional CO2 Alone for Facial Rejuvenation, With Delayed Crossover
Key Details
Gender
FEMALE
Age Range
50 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2026-10-30
Completion Date
2027-08-31
Last Updated
2026-10-27
Healthy Volunteers
Yes
Conditions
Interventions
Ultraformer MPT
Micro-focused ultrasound (Classys Inc.), single session using the 1.5 mm and 2.0 mm cartridges only. Delivered to the combination hemiface at the treatment visit and to the control hemiface at Month 3.
SmartXide Tetra Pro fractional CO2 laser
Fractional ablative CO2 laser resurfacing (DEKA M.E.L.A. S.r.l.), single full-face session at the treatment visit with identical settings on both hemifaces.
Locations (1)
Clinique Face MD
Montreal, Quebec, Canada